Studies on Hypolipidemic Agents. II. Synthesis and Pharmacological Properties of Alkylpyrazole Derivatives
スポンサーリンク
概要
- 論文の詳細を見る
A series of 5-alkylpyrazole derivatives was synthesized and evaluated for potent hypolipidemic activity in rats. Many pyrazole derivatives with an alkyl group at the 5 position of the pyrazole ring were found to possess high hypolipidemic activity. Homologation of the alkyl chain led to marked increase in activity, but introduction of other substituents at other sites on the pyrazole ring failed to enhance the activity. In addition, the replacement of the pyrazole ring with an isoxazole ring resulted in a marked decrease in activity. Among the compounds tested, 5-n-tridecylpyrazole-3-carboxylic acid (5k) exhibited the most favorable spectrum of activity and was as effective as clofibrate. This compound, 5k, showed fairly low toxicity in an acute test (LD_<50>=10.0g/kg) and hence is now undergoing further pharmacological evaluation.
- 社団法人日本薬学会の論文
- 1984-04-25
著者
-
福田 実
Research Laboratories Morishita Pharmaceutical Co. Ltd.
-
釈 邦夫
Research Laboratories, Morishita Pharmaceutical Co., Ltd.
-
大木 正彦
Research Laboratories, Morishita Pharmaceutical Co., Ltd.
-
伊勢川 順一
Research Laboratories, Morishita Pharmaceutical Co., Ltd.
-
ISEGAWA JUNICHI
Research Laboratories, Morishita Pharmaceutical Co., Ltd.
-
釈 邦夫
Department Of Development Morishita Pharmaceutical Co. Ltd.
-
大木 正彦
Research Laboratories Morishita Pharmaceutical Co. Ltd.
-
伊勢川 順一
Research Laboratories Morishita Pharmaceutical Co. Ltd.
関連論文
- Studies on Hypolipidemic Agents. IV. Influence of a New Hypolipidemic Agent, 5-Tridecylpyrazole-3-carboxylic Acid, on Cholesterol Metabolism in Rats
- Studies on Hypolipidemic Agents. III. Comparison of the Hypolipidemic Properties of 5-Tridecylpyrazole-3-carboxylic Acid and Clofibrate
- Studies on Hypolipidemic Agents. II. Synthesis and Pharmacological Properties of Alkylpyrazole Derivatives
- Studies on Hypolipidemic Agents. I. Synthesis and Pharmacological Properties of Nicotinic Acid-Ethanolamine Derivatives
- Metabolism of 4-Ethoxy-2-methyl-5-morpholino-3 (2H)-pyridazinone (M73101), a New Anti-inflammatory Agent. II. Species Differences of Metabolism and Excretion
- Metabolism of 4-Ethoxy-2-methyl-5-morpholino-3 (2H)-pyridazinone (M73101), a New Anti-inflammatory Agent. I. : Identification of the Metabolites in Rabbit and Their Pharmacological Studies
- Studies on Hypolipidemic Agents. V. : Influence of 5-Tridecylpyrazole-3-carboxylic Acid, a New Hypolipidemic Agent, on Intestinal Cholesterol Absorption in Rats
- Studies on New Antiulcer Agents. I. Synthesis and Antisecretory Activity of Pyridazine Derivatives